Poly (ADP-ribose) polymerase-1 inhibitor, 3-aminobenzamide pretreatment ameliorates lipopolysaccharide-induced neurobehavioral and neurochemical anomalies in mice

Pharmacology Biochemistry and Behavior

Volumn 133, Issue , 2015, Pages 83-91

  Sriram, Chandra Shaker ^a   Jangra, Ashok ^a   Gurjar, Satendra Singh ^a   Hussain, Md Iftikar ^b   Borah, Probodh ^b   Lahkar, Mangala ^a,c   Mohan, Pritam ^b   Bezbaruah, Babul Kumar ^a,c  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^b ASSAM AGRICULTURAL UNIVERSITY   (India)

^c GAUHATI MEDICAL COLLEGE   (India)

Author keywords

3 Aminobenzamide; Depressive like behavior; Imipramine; Lipopolysaccharide; Poly (ADP ribose) polymerase 1

Indexed keywords

3 AMINOBENZAMIDE; CATALASE; GLUTATHIONE; IMIPRAMINE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; NEUROTRANSMITTER; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NITRITE; TUMOR NECROSIS FACTOR ALPHA; 3-AMINOBENZAMIDE; BENZAMIDE DERIVATIVE; IL1B PROTEIN, MOUSE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; PARP1 PROTEIN, MOUSE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR ASSESSMENT; CHEMICAL ANALYSIS; CLINICAL ASSESSMENT; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; FORCED SWIM TEST; GENE EXPRESSION; HIPPOCAMPUS; IMMOBILITY; MALE; MOUSE; NEUROLOGIC DISEASE; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TAIL SUSPENSION TEST; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; DRUG EFFECTS; LIPID PEROXIDATION; METABOLISM; MOTOR ACTIVITY; TONIC IMMOBILITY;

MUS;

ANIMALS; BENZAMIDES; CATALASE; GLUTATHIONE; HIPPOCAMPUS; IMIPRAMINE; IMMOBILITY RESPONSE, TONIC; INTERLEUKIN-1BETA; LIPID PEROXIDATION; LIPOPOLYSACCHARIDES; MALE; MICE; MOTOR ACTIVITY; NAD; NITRITES; POLY(ADP-RIBOSE) POLYMERASE INHIBITORS; POLY(ADP-RIBOSE) POLYMERASES; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84927638914     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2015.03.022     Document Type: Article

References (71)

1. S.F. Ahmad, S.M. Attia, K.M. Zoheir, A.E. Ashour, and S.A. Bakheet Attenuation of the progression of adjuvant-induced arthritis by 3-aminobenzamide treatment Int Immunopharmacol 19 1 2014 52 59
2. S. Arias, V. Fonsalía, N. Asteggiante, and V. Bartesaghi Systemic autoimmune diseases and depressive disorders Reumatol Clin 7 6 2011 389 391
3. C. Belzung, P. Willner, and P. Philippot Depression: from psychopathology to pathophysiology Curr Opin Neurobiol 30 2015 24 30
4. S. Beneke Poly (ADP-ribose) polymerase activity in different pathologies - the link to inflammation and infarction Exp Gerontol 43 2008 605 614
5. V.C. Besson, N. Croci, R.G. Boulu, M. Plotkine, and C. Marchand-Verrecchia Deleterious poly (ADP-ribose) polymerase-1 pathway activation in traumatic brain injury in rat Brain Res 989 2003 58 66
6. E. Beutler, O. Duron, and B.M. Kelly Improved method for the determination of blood glutathione J Lab Clin Med 61 1963 882 888
7. S. Biesman, T.F. Meert, J.A. Bouwknecht, P.D. Acton, N. Davoodi, and P. De Haes Systemic immune activation leads to neuroinflammation and sickness behavior in mice Mediators Inflamm 2013 10.1155/2013/271359
8. J.D. Bremner, M. Narayan, E.R. Anderson, L.H. Staib, H.L. Miller, and D.S. Charney Hippocampal volume reduction in major depression Am J Psychiatry 157 1 2000 115 118
9. S. Cadenas, and A.M. Cadenas Fighting the stranger - antioxidant protection against endotoxin toxicity Toxicology 180 2002 45 63
10. A.F. Carvalho, J.R. Machado, and J.L. Cavalcante Augmentation strategies for treatment-resistant depression Curr Opin Psychiatry 22 2009 7 12
11. J.Y. Couturier, L. Ding-Zhou, N. Croci, M. Plotkine, and I. Margaill 3-Aminobenzamide reduces brain infarction and neutrophil infiltration after transient focal cerebral ischemia in mice Exp Neurol 184 2003 973 980
12. C.S. Custódio, B.S.F. Mello, R.C. Cordeiro, F.Y.R. de Araújo, and J.H. Chaves Time course of the effects of lipopolysaccharide on prepulse inhibition and brain nitrite content in mice Eur J Pharmacol 713 2013 31 38
13. S. Cuzzocrea, B. Zingarelli, E. Gilad, P. Hake, A.L. Salzman, and C. Szabó Protective effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthase in a carrageenan-induced model of local inflammation Eur J Pharmacol 342 1998 67 76
14. G.A. Czapski, A. Adamczyk, R.P. Strosznajder, and J.B. Strosznajder Expression and activity of PARP family members in the hippocampus during systemic inflammation: their role in the regulation of prooxidative genes Neurochem Int 62 2013 664 673
15. R. Dantzer, J.C. O'Connor, G.G. Freund, R.W. Johnson, and K.W. Kelley From inflammation to sickness and depression: when the immune system subjugates the brain Nat Rev Neurosci 9 2008 46 56
16. V.N. de Paiva, S.N. Lima, M.M. Fernandes, R. Soncini, C.A. Andrade, and A. Giusti-Paiva Prostaglandins mediate depressive-like behaviour induced by endotoxin in mice Behav Brain Res 215 2010 146 151
17. Y. Ding, Y. Zhou, Q. Lai, J. Li, V. Gordon, and F.G. Diaz Long-term neuroprotective effect of inhibiting poly (ADP-ribose) polymerase in rats with middle cerebral artery occlusion using a behavioral assessment Brain Res 915 2001 210 217
18. Y. Dowlati, N. Herrmann, W. Swardfager, H. Liu, L. Sham, and E.K. Reim A meta-analysis of cytokines in major depression Biol Psychiatry 67 2010 446 457
19. S.M. Gibney, B. McGuinness, C. Prendergast, A. Harkin, T.J. Connor, and I. Poly C-induced activation of the immune response is accompanied by depression and anxiety-like behaviours, kynurenine pathway activation and reduced BDNF expression Brain Behav Immun 28 2013 170 181
20. I. Goshen, T. Kreisel, O. Ben-Menachem-Zidon, T. Licht, J. Weidenfeld, and T. Ben-Hur Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression Mol Psychiatry 13 2008 717 728
21. Z. Guan, and J. Fang Peripheral immune activation by lipopolysaccharide decreases neurotrophins in the cortex and hippocampus in rats Brain Behav Immun 20 2006 64 71
22. T. Hajszan, A. Dow, J.L. Warner-Schmidt, K. Szigeti-Buck, N.L. Sallam, and A. Parducz Remodeling of hippocampal spine synapses in the rat learned helplessness model of depression Biol Psychiatry 65 5 2009 392 400 1
23. J. Hannestad, N. DellaGioia, and M. Bloch The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis Neuropsychopharmacology 36 2011 2452 2459
24. P. Hassa, and M. Hottiger The functional role of poly (ADP-ribose) polymerase 1 as novel coactivator of NF-κB in inflammatory disorders Cell Mol Life Sci 59 2002 1534 1553
25. C.J. Henry, Y. Huang, A. Wynne, M. Hanke, J. Himler, and M.T. Bailey Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia J Neuroinflammation 5 2008 2094 2095
26. F. Holsboer Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy J Affect Disord 62 1-2 2001 77 91
27. A. Jangra, A.K. Datusalia, S. Khandwe, and S.S. Sharma Amelioration of diabetes-induced neurobehavioral and neurochemical changes by melatonin and nicotinamide: Implication of oxidative stress-PARP pathway Pharmacol Biochem Behav 114 2013 43 51
28. A. Jangra, A.K. Datusalia, and S.S. Sharma Reversal of neurobehavioral and neurochemical alterations in STZ-induced diabetic rats by FeTMPyP, a peroxynitrite decomposition catalyst and 1,5-isoquinolinediol a poly (ADP-ribose) polymerase inhibitor Neurol Res 36 7 2013 619 626
29. A. Jangra, M.M. Lukhi, K. Sulakhiya, C.C. Baruah, and M. Lahkar Protective effect of mangiferin against lipopolysaccharide-induced depressive and anxiety-like behaviour in mice Eur J Pharmacol 740 2014 337 345
30. D. Karlović, A. Serretti, N. Vrkić, M. Martinac, and D. Marčinko Serum concentrations of CRP, IL-6, TNF-α and cortisol in major depressive disorder with melancholic or atypical features Psychiatry Res 198 2012 74 80
31. M. Khassaf, A. McArdle, C. Esanu, A. Vasilaki, F. McArdle, and R. Griffiths Effect of vitamin C supplements on antioxidant defence and stress proteins in human lymphocytes and skeletal muscle J Physiol 549 2003 645 652
32. R.W. Lam, G.S. Malhi, R.S. McIntyre, K. Demyttenaere, P. Gorwoo, and E.E. Michalak Fatigue and occupational functioning in major depressive disorder Aust N Z J Psychiatry 47 2013 989 991
33. X. Li, M.A. Frye, and R.C. Shelton Review of pharmacological treatment in mood disorders and future directions for drug development Neuropsychopharmacology 37 2012 77 101
34. D. Liu, Z. Wang, S. Liu, F. Wang, S. Zhao, and A. Hao Anti-inflammatory effects of fluoxetine in lipopolysaccharide (LPS)-stimulated microglial cells Neuropharmacology 61 2011 592 599
35. F.E. Lotrich Inflammatory cytokine-associated depression Brain Res 2014 10.1016/j.brainres.2014.06.032
36. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J Biol Chem 193 1951 265 275
37. M. Maes Evidence for an immune response in major depression: a review and hypothesis Prog Neuropsychopharmacol Biol Psychiatry 19 1995 11 38
38. M. Maes The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression Neuro Endocrinol Lett 29 2008 287 291
39. T. Maria Michel, D. Pulschen, and J. Thome The role of oxidative stress in depressive disorders Curr Pharm Des 18 2012 5890 5899
40. D. Martin-Oliva, R.M. Ferrer-Martin, A.M. Santos, M.C. Carrasco, A. Sierra, and J.L. Marin-Teva Simultaneous cell death and upregulation of poly (ADP-ribose) polymerase-1 expression in early postnatal mouse retina Invest Ophthalmol Vis Sci 52 10 2011 7445 7454
41. B.S. McEwen Stress and hippocampal plasticity Annu Rev Neurosci 22 1999 105 122
42. S.I. Miller, R.K. Ernst, and M.W. Bader LPS, TLR4 and infectious disease diversity Nat Rev Microbiol 3 2005 36 46
43. F. Moroni, A. Cozzi, A. Chiarug, L. Formentini, E. Camaioni, and D.E. Pellegrini-Giampietro Long-lasting neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly(ADP-ribose) polymerase Br J Pharmacol 165 2012 1487 1500
44. T. Nagayama, R.P. Simon, D. Chen, D.C. Henshall, W. Pei, and R.A. Stetler Activation of poly(ADP-ribose) polymerase in the rat hippocampus may contribute to cellular recovery following sublethal transient global ischemia J Neurochem 74 4 2000 1636 1645
45. E.J. Nestler, M. Barrot, R.J. DiLeone, A.J. Eisch, S.J. Gold, and L.M. Monteggia Neurobiology of depression Neuron 34 2002 13 25
46. J. Nisselbaum, and S. Green A simple ultramicro method for determination of pyridine nucleotides in tissues Anal Biochem 27 1969 212 217
47. E. Obuchowicz, A.M. Bielecka, M. Paul-Samojedny, A. Pudełko, and J. Kowalski Imipramine and fluoxetine inhibit LPS-induced activation and affect morphology of microglial cells in the rat glial culture Pharmacol Rep 66 2014 34 43
48. Y. Ohgi, T. Futamura, T. Kikuchi, and K. Hashimoto Effects of antidepressants on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration Pharmacol Biochem Behav 103 2013 853 859
49. H. Ohkawa, N. Ohishi, and K. Yagi Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal Biochem 95 1979 351 358
50. F.J. Oliver, J. Ménissier-de Murcia, C. Nacci, P. Decker, R. Andriantsitohaina, and S. Muller Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice EMBO J 18 1999 4446 4454
51. G. Patki, N. Solanki, F. Atrooz, F. Allam, and S. Salim Depression, anxiety-like behavior and memory impairment are associated with increased oxidative stress and inflammation in a rat model of social stress Brain Res 1539 2013 73 86
52. E.S. Paykel Depression: major problem for public health Epidemiol Psichiatr Soc 15 1 2006 4 10
53. R. Porsolt, A. Bertin, and M. Jalfre Behavioral despair in mice: a primary screening test for antidepressants Arch Int Pharmacodyn Ther 229 1977 327 336
54. C.L. Raison, and A.H. Miller Depression in cancer: new developments regarding diagnosis and treatment Biol Psychiatry 54 3 2003 283 294 1
55. C.L. Raison, L. Capuron, and A.H. Miller Cytokines sing the blues: inflammation and the pathogenesis of depression Trends Immunol 27 2006 24 31
56. S.S. Rizzo, S. Neal, Z. Hughes, M. Beyna, S. Rosenzweig-Lipson, and S. Moss Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes Transcult Psychiatry 2012 10.1038/tp.2012.120
57. A. Salazar, B.L. Gonzalez-Rivera, L. Redus, J.M. Parrott, and J.C. O'Connor Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge Horm Behav 62 2012 202 209
58. M. Sharpe, J. Walker, C. Holm Hansen, P. Martin, S. Symeonides, and C. Gourley Lancet 384 9948 2014 1099 1108 [20]
59. C. Song, and H. Wang Cytokines mediated inflammation and decreased neurogenesis in animal models of depression Prog Neuropsychopharmacol Biol Psychiatry 35 2011 760 768
60. C.S. Sriram, A. Jangra, E.R. Kasala, L.N. Bodduluru, and B.K. Bezbaruah Targeting poly (ADP-ribose) polymerase1 in neurological diseases: a promising trove for new pharmacological interventions to enter clinical translation Neurochem Int 76 2014 70 81
61. C.S. Sriram, A. Jangra, R.M. Madhana, S.S. Gurjar, P. Mohan, and B.K. Bezbaruah Multiple facets of poly(ADP-ribose) polymerase-1 in neurological diseases Neural Regen Res 10 1 2015 49 51
62. L. Steru, R. Chermat, B. Thierry, and P. Simon The tail suspension test: a new method for screening antidepressants in mice Psychopharmacology (Berl) 85 1985 367 370
63. B.A. Stoica, D.J. Loane, Z. Zhao, S.V. Kabadi, M. Hanscom, and K.R. Byrnes PARP-1 inhibition attenuates neuronal loss, microglia activation and neurological deficits after traumatic brain injury J Neurotrauma 31 2014 758 772
64. C. Tayade, D. Hilchie, H. He, Y. Fang, L. Moons, and P. Carmeliet Genetic deletion of placenta growth factor in mice alters uterine NK cells J Immunol 178 7 2007 4267 4275
65. V.S. Tomaz, R.C. Cordeiro, A.M.N. Costa, D.F. de Lucena, H.V. Nobre Júnior, and F.C.F. de Sousa Antidepressant-like effect of nitric oxide synthase inhibitors and sildenafil against lipopolysaccharide-induced depressive-like behavior in mice Neuroscience 268 2014 236 246
66. R. Uher, O. Mors, M. Rietschel, A. Rajewska-Rager, A. Petrovic, and A. Zobel Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the genome-based therapeutic drugs for depression (GENDEP) study J Clin Psychiatry 72 2011 1478 1484
67. Z. Wang, Q. Zhang, L. Yuan, S. Wang, L. Liu, and X. Yang The effects of curcumin on depressive-like behavior in mice after lipopolysaccharide administration Behav Brain Res 2014 10.1016/j.bbr.2014.08.018
68. X. Wu, P. Wang, Y.H. Liu, and Y.-X. Xue Effects of poly (ADP-ribose) polymerase inhibitor 3-aminobenzamide on blood-brain barrier and dopaminergic neurons of rats with lipopolysaccharide-induced Parkinson's disease J Mol Neurosci 53 2014 1 9
69. S. Zeugmann, N. Buehrsch, M. Bajbouj, I. Heuser, I. Anghelescu, and A. Quante Childhood maltreatment and adult proinflammatory status in patients with major depression Psychiatr Danub 25 2013 227 235
70. J.C. Zhang, J. Wu, Y. Fujita, W. Yao, Q. Ren, and C. Yang Antidepressant effects of TrkB ligands on depression-like behavior and dendritic changes in mice after inflammation Int J. Neuropsychopharmacol 18 2015 1 12
71. P.A. Zunszain, C. Anacker, A. Cattaneo, L.A. Carvalho, and C.M. Pariante Glucocorticoids, cytokines and brain abnormalities in depression Prog Neuropsychopharmacol Biol Psychiatry 35 3 2011 722 729 [29]